Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial: An International Randomised Controlled Trial Evaluating Apixaban Versus No Anticoagulation in Patients Undergoing General Abdominal, Gynecologic and Urologic Surgery

NCT06523959 is registered in ClinicalTrials.gov with Clinical Urology and Epidemiology Working Group as lead sponsor.

NCT NCT06523959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06523959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial: An International Randomised Controlled Trial Evaluating Apixaban Versus No Anticoagulation in Patients Undergoing General Abdominal, Gynecologic and Urologic Surgery
Lead sponsor
Clinical Urology and Epidemiology Working Group
Phase
Phase 4
Overall status
Recruiting
Start date
June 6, 2024
Completion date
December 31, 2028
Enrollment
5,436 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, venous thromboembolism